MRI-guided Radiation Therapy Systems Revenue to Top US$2.89 Billion by 2033

The market for MRI-guided radiation therapy systems is currently valued at US$ 545.1 million and is anticipated to generate US$ 2.89 billion in sales by the end of 2033. According to Fact.MR study, sales of MRI-guided radiation therapy systems will significantly increase at a 18.1% CAGR over the next 10 years.

Since MRI-guided radiation therapy systems are widely used in the treatment of cancer, the rising incidence of various malignancies is anticipated to significantly boost market growth over the course of the forecast period. It is also projected that rising capital spending on establishing healthcare infrastructure in developing economies would increase shipments of MRI-guided radiation therapy equipment in the future.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁:
https://www.factmr.com/connectus/sample?flag=S&rep_id=2572?AS

𝗗𝗿𝗶𝘃𝗲𝗿𝘀
• The rising prevalence of cancer across the globe is driving the demand for advanced radiation therapy systems, including MRI-guided radiation therapy systems.
• The development of new and advanced radiation therapy systems, such as MRI-guided radiation therapy systems, is driving the market growth.
• The growing investments in research and development activities aimed at developing innovative radiation therapy systems are expected to drive market growth.
• Governments across the globe are investing in the development of advanced radiation therapy systems, which is driving market growth.
• MRI-guided radiation therapy systems offer non-invasive treatment options, which are increasingly preferred by patients, thereby supporting the growth of the market.
• The rising awareness among patients and healthcare providers about the benefits of MRI-guided radiation therapy is boosting the market growth.

𝗧𝗿𝗲𝗻𝗱𝘀

• Hybrid systems that combine MRI-guided radiation therapy with other imaging modalities, such as PET or CT, are gaining popularity, as they provide improved accuracy and efficiency in cancer treatment.
• AI and ML algorithms are being developed to optimize radiation therapy planning and improve treatment outcomes.
• Compact and mobile systems are being developed, which can be used in smaller healthcare facilities and in rural areas, where access to advanced medical equipment is limited.
• The focus is shifting towards patient-centric care, with personalized treatment planning and delivery based on individual patient characteristics and needs.
• Proton therapy is an advanced form of radiation therapy that is gaining popularity due to its improved precision and reduced side effects, and MRI-guided proton therapy systems are being developed.
• Key players in the market are entering into collaborations and partnerships to develop innovative and advanced MRI-guided radiation therapy systems and expand their market presence.

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

MRI-guided Radiation therapy systems market is highly consolidated. Companies such as Elekta AB and ViewRay are dominating the global market and currently, account for around 80% of the global market share.
• Launched in 2021, the Elekta Harmony system combines advanced MRI imaging with linear accelerator radiation therapy for improved treatment accuracy and precision.
• MRIdian Linac system was launched in 2021. And this combines MRI-guided radiation therapy with a linear accelerator for improved treatment precision and reduced treatment times.
• Moreover, ViewRay and RaySearch announced a collaboration in 2021 to develop new treatment planning and delivery software for the MRIdian Linac system.
In addition to this, companies are receiving FDA approvals to expand their sales potential across various countries.
• C-RAD received FDA clearance for its SIGRT system in 2021, which provides real-time monitoring and motion management for radiation therapy.

𝗧𝗼𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀

• Elekta AB
• ViewRay Technologies Inc.
• Koninklijke Philips N.V

𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲:

United States is expected to account for a substantial share in the market. Various factors such as developed healthcare infrastructure and the significant presence of reimbursement policies in the United States are expected to boost the adoption of MRI-guided radiation therapy systems.

o Moreover, as per American Cancer Society website, nearly 1.9 million new cases of cancer were recorded in year 2022. The rising senescent population and the presence of key radiation therapy providers is expected to support the growth of the market.
• In European countries, mortality rate of cancer has been increasing for the past few years and this trend is expected to boost the adoption of MRI-guided Radiation therapy systems.

𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

• By Product :
o Linac MR-RT Systems
o Software

• By MR Dimension :
o 0.5 Tesla MR Scanners
o 1.5 Tesla MR Scanners

• By End User :
o Hospitals
o Radiotherapy Centers
o Cancer Research Institutes

• By Region :
o North America
o Latin America
o Europe
o APAC
o MEA

𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀

• What will be the estimated size of the Market in 2023?
• At what rate will the global MRI-guided Radiation Therapy Systems sales grow until 2033?
• Which are the factors hampering the MRI-guided Radiation Therapy Systems demand?
• Which region will spearhead the growth in the global industry during 2023-2033?
• Which are the factors driving sales in the MRI-guided Radiation Therapy Systems Market during the forecast period?

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=2572?AS

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year.

This release was published on openPR.